OUR RESOURCES

All of Biotech and Money's content, in one place.

 

DEALS WATCH

Medius Deal Watch September 2017

The trend we have noted previously in the decline in the number of pharma M...

Read More

Medius Deal Watch August 2017

There is plenty of evidence that the number and value of biopharma M&A and ...

Read More

Medius Deal Watch July 2017

The cheque books have been out in force in July, and payments were for subs...

Read More

Medius Deal Watch May Part II

Good morning, good morning

Read More

Medius Deal Watch May 2017 Part I

Following the scarcity of billion dollar headline deals in March, this mont...

Read More
VIEW MORE

EXECUTIVE AND EXPERT INSIGHTS

SkinBioTherapeutics on track with post-IPO milestones

Key learnings: SkinBioTherapeutics’ SkinBiotix® technology has passed third...

Read More

Winner’s spotlight: Bicycle Therapeutics

Key learnings: Bicycle Therapeutics was named Life Science Growth Company o...

Read More

What does the future hold for digital health investment?

Key learnings: The Biotech and Money community gathered for Biotechs and th...

Read More

Investor insights: The path to career success in life sciences

Key learnings: VC investors gathered at the Future Investor Forum 2017 to d...

Read More

2017 Biotech and Money Assembly and Awards Gala Dinner

A record number turned out for the annual Biotech and Money Assembly and Aw...

Read More

From Strength to Strength: Unpacking Clinigen's Route to Success

Putting patient care at the heart of its mission, Clinigen’s unique approac...

Read More

[Webinar Recording] The Current State of the M&A Landscape

Are you considering M&A transactions as a potential exit strategy, step to ...

Read More

[Webinar Recording] The Anatomy of a successful IPO

On the 27th June, we spoke to an expert panel to discuss the how, when, wha...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

How will China’s Cybersecurity Law impact the life sciences sector?

Key learnings: The Cybersecurity Law came into effect in China’s territorie...

Read More

Advice for investors

This blog is a summary of Chapter 6 of the Advanced Therapies Investment Re...

Read More

Understanding Biopharma Interest

This blog is a summary of Chapter 5 of the Advanced Therapies Investment Re...

Read More

Manufacturing Commercial Operations and Supply Chain

This blog is a summary of Chapter 4 of the Advanced Therapies Investment Re...

Read More

Building Value for Cell and Gene Therapies and Establishing Market Access Pathways

This blog is a summary of Chapter 3 of the Advanced Therapies Investment Re...

Read More

Understanding Cell & Gene Therapy Pipelines

This blog is a summary of Chapter 2 of the Advanced Therapies Investment Re...

Read More

Overview of Advanced Therapy Industry

This blog is a summary of Chapter 1 of the Advanced Therapies Investment Re...

Read More

Must-Know Finance Concepts for Life Sciences Valuations

By John Selig, Co-Founder and Managing Partner, Mavericks Capital When sell...

Read More
View More

INVESTORVIEWS

Investorview - Edward Van Wezel, Managing Director, Biogeneration Ventures

We recently sat with Edward Van Wezel, Managing Director and Founder of Bio...

Read More

Investorview - Investing in a Digital Future with Christoph Ruedig, Partner, Albion Capital

Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

Read More

Investorview – Precision Investing with Jay Goth, Managing Partner, Forentis Fund

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General Partner at ‎Julz Co

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More
VIEW MORE